RMC No. 19-2023: Publishes the January 4, 2023 letter from the Food and Drug Administration of the DOH endorsing updates to the List of VAT-Exempt Medicines under RA No. 10963 (TRAIN Law) and RA No. 11534 (CREATE Act)

Summary

RMC No. 19-2023 publishes the January 4, 2023 letter of the Food and Drug Administration endorsing updates to the List of VAT-Exempt Medicines under RA No. 11534 (CREATE Act).

Key points

1. Letter published. The letter comes from FDA Director General Samuel A. Zacate and is dated January 4, 2023. It endorses updates to the List of VAT-Exempt Medicines.
2. Items added to the list. The updated list now includes certain medicines and medical devices for COVID-19 treatment.
3. When the exemption starts. Per Q&A No. 1 of RMC No. 99-2021, the VAT exemption of the covered items takes effect on the date the FDA publishes the list updates.

Deadlines and effectivity

• Letter dated January 4, 2023
• VAT exemption effective on FDA publication date of the list updates

Summary by Tax Resources PH. It is not a substitute for the full text of the issuance or professional advice.